Related references
Note: Only part of the references are listed.Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms
Mark Tristan J. Quimque et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Chemical-informatics approach to COVID-19 drug discovery: Monte Carlo based QSAR, virtual screening and molecular docking study of somein-housemolecules as papain-like protease (PLpro) inhibitors
Sk. Abdul Amin et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Alexander E. Gorbalenya et al.
NATURE MICROBIOLOGY (2020)
Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms
Abdul Mannan Baig et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N=4532)
M. Montopoli et al.
ANNALS OF ONCOLOGY (2020)
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection
Huan Han et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
Daniel E. Freedberg et al.
GASTROENTEROLOGY (2020)
2019 novel coronavirus (2019-nCoV) outbreak: A new challenge
Tommaso Lupia et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2020)
Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients
Sophie Testa et al.
INTERNAL AND EMERGENCY MEDICINE (2020)
Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development
Brooke Benner et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
Silencing of immune activation with methotrexate in patients with COVID-19
Farinaz Safavi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019 A Review
Adeel S. Zubair et al.
JAMA NEUROLOGY (2020)
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
David E. Gordon et al.
NATURE (2020)
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a Case Report and Review of ABL Kinase Involvement in Viral Infection
Elisabetta Abruzzese et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2020)
Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
Sebastiano Bruno Solerte et al.
ACTA DIABETOLOGICA (2020)
Repurposed GI Drugs in the Treatment of COVID-19
Enrik John T. Aguila et al.
DIGESTIVE DISEASES AND SCIENCES (2020)
Repurposing minocycline for COVID-19 management: mechanisms, opportunities, and challenges
Harmanjit Singh et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2020)
COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)
Yang Song et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Targeting the NLRP3 Inflammasome in Severe COVID-19
Tracey L. Freeman et al.
FRONTIERS IN IMMUNOLOGY (2020)
Exploring Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors for Organ Protection in COVID-19
Beatriz Fernandez-Fernandez et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The Inhibitory Effect of Curcumin on Virus-Induced Cytokine Storm and Its Potential Use in the Associated Severe Pneumonia
Ziteng Liu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
The renin-angiotensin-aldosterone system: Role in pathogenesis and potential therapeutic target in COVID-19
Cassia L. Braga et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2020)
The Three Italy of the COVID-19 epidemic and the possible involvement of SARS-CoV-2 in triggering complications other than pneumonia
Carla Prezioso et al.
JOURNAL OF NEUROVIROLOGY (2020)
How SARS-Cov-2 can involve the central nervous system. A systematic analysis of literature of the department of human neurosciences of Sapienza University, Italy
Daniele Armocida et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2020)
Can beta-adrenergic blockers be used in the treatment of COVID-19?
Natesan Vasanthakumar
MEDICAL HYPOTHESES (2020)
Antiviral anticoagulation
Edward L. G. Pryzdial et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)
Copanlisib synergizes with conventional and targeted agents including venetoclax in B- and T-cell lymphoma models
Chiara Tarantelli et al.
BLOOD ADVANCES (2020)
Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models
Tatsuo Sugawara et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Canagliflozin review - safety and efficacy profile in patients with T2DM
Haroon Jakher et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2019)
Anti-infective Properties of the Golden Spice Curcumin
Dimas Praditya et al.
FRONTIERS IN MICROBIOLOGY (2019)
Fixed-dose combination of umeclidinium and vilanterol for patients with chronic obstructive pulmonary disease: A systematic review
Wijdan H. Ramadan et al.
CLINICAL RESPIRATORY JOURNAL (2019)
Long-term safety and efficacy of acotiamide in functional dyspepsia (postprandial distress syndrome)results from the European phase 3 open-label safety trial
J. Tack et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2018)
Antibody-assisted target identification reveals afatinib, an EGFR covalent inhibitor, down-regulating ribonucleotide reductase
Cheng-Han Yu et al.
Oncotarget (2018)
Curcumin interacts directly with the Cysteine 259 residue of STAT3 and induces apoptosis in H-Ras transformed human mammary epithelial cells
Young-Il Hahn et al.
SCIENTIFIC REPORTS (2018)
Afatinib in advanced NSCLC: a profile of its use
Emma D. Deeks et al.
DRUGS & THERAPY PERSPECTIVES (2018)
The ChEMBL database in 2017
Anna Gaulton et al.
NUCLEIC ACIDS RESEARCH (2017)
The Role of ErbB Receptors in Infection
Jemima Ho et al.
TRENDS IN MICROBIOLOGY (2017)
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
Nicholas Butowski et al.
NEURO-ONCOLOGY (2016)
P-glycoprotein differentially affects escitalopram, levomilnacipran, vilazodone and vortioxetine transport at the mouse blood-brain barrier in vivo
Christoffer Bundgaard et al.
NEUROPHARMACOLOGY (2016)
Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations
Dilek Keskin et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Role of arformoterol in the management of COPD
Paul King
International Journal of Chronic Obstructive Pulmonary Disease (2016)
Edoxaban: A Comprehensive Review of the Pharmacology and Clinical Data for the Management of Atrial Fibrillation and Venous Thromboembolism
Zachary A. Stacy et al.
CARDIOLOGY AND THERAPY (2016)
The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities
Samuel Genheden et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability
Shinya Nishio et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2015)
Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis
Jason Kindrachuk et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
Julie Dyall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Mechanism of action of the SPARI vilazodone: serotonin 1A partial agonist and reuptake inhibitor
Stephen M. Stahl
CNS SPECTRUMS (2014)
Clinical Use of Rivaroxaban: Pharmacokinetic and Pharmacodynamic Rationale for Dosing Regimens in Different Indications
Toby Trujillo et al.
DRUGS (2014)
Docking Covalent Inhibitors: A Parameter Free Approach To Pose Prediction and Scoring
Kai Zhu et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
G. Madhavi Sastry et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
Rachelle S. Doody et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Into the Eye of the Cytokine Storm
Jennifer R. Tisoncik et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2012)
Lafutidine, a unique histamine H2-receptor antagonist, inhibits distention-induced gastric acid secretion through an H2 receptor-independent mechanism
Motoko Nakano et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Formulary Management of the Protease Inhibitors Boceprevir and Telaprevir for Chronic Hepatitis C Virus
Alexandra Tungol et al.
JOURNAL OF MANAGED CARE PHARMACY (2011)
The resurgence of covalent drugs
Juswinder Singh et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
The VSGB 2.0 model: A next generation energy model for high resolution protein structure modeling
Jianing Li et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2011)
ConfGen: A Conformational Search Method for Efficient Generation of Bioactive Conformers
K. Shawn Watts et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
Curcumin: From ancient medicine to current clinical trials
H. Hatcher et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Michael acceptors as cysteine protease inhibitors
Maria M. M. Santos et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2007)
MD-2 as the target of curcumin in the inhibition of response to LPS
Helena Gradisar et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus
Chih-Chun Wen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Optimizing fragment and scaffold docking by use of molecular interaction fingerprints
Gilles Marcou et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Structural interaction fingerprints: A new approach to organizing, mining, analyzing, and designing protein-small molecule complexes
J Singh et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2006)
Structural interaction fingerprint (SIFt): A novel method for analyzing three-dimensional protein-ligand binding interactions
Z Deng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Amprenavir: A new human immunodeficiency virus type 1 protease inhibitor
HB Fung et al.
CLINICAL THERAPEUTICS (2000)
Share Paper
